Advertisement

Topics

Agenus To Present on Lead Antibody Programs AGEN1884 (CTLA-4) and AGEN2034 (PD-1) at SITC 2017

08:45 EST 9 Nov 2017 | BioMedReports - Blog

The Agenus strategy is built on a foundation of speed, innovation, and combinations, each critical elements for success in I-O. Agenus is delivering innovations through

Read more...

Original Article: Agenus To Present on Lead Antibody Programs AGEN1884 (CTLA-4) and AGEN2034 (PD-1) at SITC 2017

NEXT ARTICLE

More From BioPortfolio on "Agenus To Present on Lead Antibody Programs AGEN1884 (CTLA-4) and AGEN2034 (PD-1) at SITC 2017"

Advertisement
Quick Search
Advertisement
Advertisement